The CDC says the number of people affected by an E.coli outbreak linked to Costco chicken salad will likely grow.» Read More
China's economic slowdown isn't spooking Morgan Stanley, which has its eye on the mainland's "new economy."
RightEye's eye-tracking software, Neuro Vision, shows promise in diagnosing concussions.
Sky-high deductibles are leaving some newly insured feeling nearly as vulnerable as they were before they had coverage, The NYT reports.
The NFL's "Color Rush" campaign introduced controversy Thursday on Twitter from colorblind users who could not distinguish between the two uniforms.
Shares of over-the-counter drugmaker Perrigo sank early Friday after its stock owners rejected a hostile, $26 billion takeover bid from Mylan.
A new report says J. Michael Pearson got more than 500,000 Valeant share units in "error" in 2013.
A new government survey finds that more than 2 percent of U.S. kids have been diagnosed with autism — or 1 in 45 children aged 3 and older.
A proposed federal rule could effect close to one million homes, says The New York Times. Here's how.
Companies' health care costs has gone down, yet employees are still paying more, says USA Today. Find out why.
At an event honoring Buffett's 50 years at Berkshire Hathaway, Bill Ackman openly criticized Buffett for his stake in Coca-Cola.
The start-up Babyscripts is helping moms have healthier pregnancies by monitoring their vitals via an app.
About 1 in 5 Medicare dollars is spent on this disease that affects over 5 million Americans. Yet not enough is being done to find a cure.
The head of short-selling firm Citron Research on Tuesday called for more disclosures about Mallinckrodt's main drug.
Nestle has restarted sales of its Maggi noodles in India after food safety fears left the company with $77m in losses, the FT reports.
As of last week, Philidor Rx Services has stopped adjudicating insurance claims for drugs, Valeant CEO Mike Pearson said.
Mallinckrodt's CEO rejects Citron Research's contention that it would face challenges being reimbursed for a high-priced specialty drug.
Valeant's stock has plunged significantly on the heels of concerns about the drugmaker's dealings with an outside pharmacy.
Chuck Rosenberg, chief of the DEA, said that smoking marijuana should not be considered medical treatment on Wednesday, calling the notion a "joke."
Some of those generic pills you buy at the drug store could change ownership Friday.
Valeant stock has crumbled amid multiple probes over its relationship with a specialty pharmacy, the Financial Times reports.
Get the best of CNBC in your inbox